MedTrace Logo

Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury

NCT03236064 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-01-26

No results posted yet for this study

Summary

This study will evaluate the safety and efficacy of PEG 3350 for use in nerve repair.

Conditions

  • Injury of Other Nerves at Wrist and Hand Level of Unspecified Arm, Initial Encounter

Interventions

DRUG

Polyethylene Glycols

Demonstrate more rapid and increased return of function by PEG-fusion compared to best current nerve repair techniques

Sponsors & Collaborators

  • Neuraptive Therapeutics Inc.

    collaborator INDUSTRY

  • WellSpan Health

    lead OTHER

Principal Investigators

  • Richard C Trevino, MD · WellSpan York Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2024-05-31
Completion
2024-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03236064 on ClinicalTrials.gov